NO20044979L - Nye biomaterialer, deres fremstilling og anvendelse - Google Patents

Nye biomaterialer, deres fremstilling og anvendelse

Info

Publication number
NO20044979L
NO20044979L NO20044979A NO20044979A NO20044979L NO 20044979 L NO20044979 L NO 20044979L NO 20044979 A NO20044979 A NO 20044979A NO 20044979 A NO20044979 A NO 20044979A NO 20044979 L NO20044979 L NO 20044979L
Authority
NO
Norway
Prior art keywords
precipitate
components
additional
component
amphilic
Prior art date
Application number
NO20044979A
Other languages
English (en)
Inventor
Gyorgy Lajos Kis
Lajos Szente
Christian Schoch
Jozsef Szejtli
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20044979L publication Critical patent/NO20044979L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Foreliggende oppfinnelse angår nye materialer, særlig biomaterialer, i form av et presipitat, som innbefatter minst en anionisk polymerkomponent som sådan er løselig i vann og en amfilisk ammoniumtypekomponent, hvilket presipitat oppnås ved en fremgangsmåte som inkluderer følgende trinn: 1. bringe den anioniske polymerkomponenten og en cyklodekstrinkomponent i kontakt i et vandig medium, og 2. tilsette til blandingen oppnådd i trinn 1 nevnte amfiliske ammoniumtypekomponent, hvori nevnte komponenter er tilstede i mengder effektive til å danne nevnte presipitat, og foretrukket for de korresponderende presipitatene innbefatter de ytterligere nevnte cyklodekstrinkomponent. Begge typer presipitat kan eventuelt innbefatte en eller flere ytterligere komponenter. Presipitatene er særlig anvendelige for kontrollert frigivelses depotformuleringer egnet for langtidsvirkende levering av nevnte ytterligere komponenter. De ytterligere komponentene inkorporert i presipitatene kan være farmasøytiske forbindelser, pesticider, agrokjemikalier, fargestoffer, diagnostiske midler, enzymer, matvarer etc.
NO20044979A 2002-04-19 2004-11-16 Nye biomaterialer, deres fremstilling og anvendelse NO20044979L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02008809 2002-04-19
PCT/EP2003/004076 WO2003089008A1 (en) 2002-04-19 2003-04-17 Novel biomaterials, their preparation and use

Publications (1)

Publication Number Publication Date
NO20044979L true NO20044979L (no) 2004-11-16

Family

ID=29225593

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044979A NO20044979L (no) 2002-04-19 2004-11-16 Nye biomaterialer, deres fremstilling og anvendelse

Country Status (20)

Country Link
US (3) US20050163853A1 (no)
EP (1) EP1499361B1 (no)
JP (1) JP4648632B2 (no)
KR (1) KR101121675B1 (no)
CN (1) CN1646171B (no)
AU (1) AU2003224099B2 (no)
BR (1) BR0309340A (no)
CA (1) CA2484100C (no)
CO (1) CO5611168A2 (no)
ES (1) ES2392964T3 (no)
HK (1) HK1073070A1 (no)
IL (1) IL164627A (no)
MX (1) MXPA04010325A (no)
NO (1) NO20044979L (no)
NZ (1) NZ535810A (no)
PL (1) PL215579B1 (no)
PT (1) PT1499361E (no)
RU (1) RU2321597C2 (no)
WO (1) WO2003089008A1 (no)
ZA (1) ZA200407794B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
BRPI0506983A (pt) * 2004-01-20 2007-07-03 Allergan Inc composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico
WO2006011044A1 (en) * 2004-07-22 2006-02-02 Pfizer Products Inc. Amorphous cyclodextrin compositions
US20060089590A1 (en) * 2004-10-27 2006-04-27 John Higuchi Methods and devices for sustained in-vivo release of an active agent
EP1787658B1 (en) 2005-11-10 2012-03-14 CHEMI S.p.A. Sustained release formulations of somatostatin analogue inhibitors of growth hormone
US20100155242A1 (en) * 2006-09-04 2010-06-24 Arkray, Inc. Method of Analyzing a Sample by Capillary Electrophoresis
CN101501484B (zh) * 2006-09-04 2012-12-26 独立行政法人产业技术综合研究所 通过毛细管电泳法分析试样的方法
JP2009186445A (ja) * 2008-02-08 2009-08-20 Arkray Inc キャピラリー電気泳動法によるヘモグロビンの分析方法およびそれに用いる試薬
EP2060913B1 (en) * 2006-09-04 2016-11-02 National Institute of Advanced Industrial Science and Technology Method for analysis of sample by capillary electrophoresis
CA2753641C (en) * 2009-02-25 2014-09-16 Supratek Pharma, Inc. Bendamustine cyclopolysaccharide compositions
US8389558B2 (en) * 2009-07-20 2013-03-05 Supratek Pharma Inc. Bendamustine amphiphilic anionic compositions
US20110015245A1 (en) * 2009-07-20 2011-01-20 Valery Alakhov Bendamustine amphiphilic cationic compositions
RU2552927C2 (ru) 2010-03-13 2015-06-10 Истпонд Лабораториз Лимитед Жиросвязывающая композиция
US8383663B2 (en) 2010-07-19 2013-02-26 Supratek Pharma Inc. Bendamustine anionic-catioinic cyclopolysaccharide compositions
BR112013016809A2 (pt) 2010-12-31 2016-09-27 Eastpond Lab Ltd composições de hidratação celular
US20120171184A1 (en) 2010-12-31 2012-07-05 Lajos Szente Cellular hydration compositions
CN103347386B (zh) * 2011-02-10 2016-08-10 荷兰联合利华有限公司 抗微生物组合物
MX356582B (es) 2012-01-18 2018-06-05 Surmodics Inc Recubrimiento para dispositivo medico lubrico con bajo nivel de material particulado.
EP2928500B1 (en) * 2012-12-04 2019-03-06 Phosphorex Inc. Microparticles and nanoparticles having negative surface charges
JP6449249B2 (ja) * 2013-05-17 2019-01-09 マーケット ユニバーシティー イオン性液体組成物から形成される構造多糖および大環状化合物を含有する複合材料
JP5673756B2 (ja) * 2013-08-20 2015-02-18 東洋紡株式会社 医療用材料
RU2597085C2 (ru) * 2013-11-07 2016-09-10 Федеральное государственное бюджетное учреждение науки Институт биологии моря им. А.В. Жирмунского Дальневосточного отделения Российской академии наук (ИБМ ДВО РАН) Имплантируемый матриксный материал для регенеративной медицины и способ его получения (варианты)
WO2016206738A1 (en) 2015-06-24 2016-12-29 Kao Germany Gmbh Hair treatment process
US11174447B2 (en) 2015-12-29 2021-11-16 Surmodics, Inc. Lubricious coatings with surface salt groups
US10342898B2 (en) * 2015-12-29 2019-07-09 Surmodics, Inc. Lubricious coatings with surface salt groups
EP3528856B1 (en) 2016-10-18 2023-07-12 Marquette University Composite materials containing structural polymers and photoreactive nitric oxide releasing agents and uses thereof for wound dressings
MX2022012532A (es) 2020-04-06 2023-03-15 Eastpond Laboratories Ltd Composiciones y métodos para promover la hidratación celular.
CN114344557A (zh) * 2022-01-10 2022-04-15 山东万容生物科技有限公司 一种含环糊精的水胶体敷料及其制备方法
WO2023212740A1 (en) * 2022-04-29 2023-11-02 Drexel University Surfactant-impregnated mof-coated fabric for antimicrobial applications

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670837A (no) * 1964-10-14 1966-01-31
JPS61251616A (ja) * 1985-04-30 1986-11-08 Agency Of Ind Science & Technol 溶質の放出量の制御方法
JPS6416728A (en) * 1987-07-07 1989-01-20 Santen Pharmaceutical Co Ltd Aqueous preparation
JPH03234770A (ja) * 1990-02-09 1991-10-18 Nippon Shokubai Kagaku Kogyo Co Ltd 電気刺激応答性ゲルの製法
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5464650A (en) * 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
SE9303627D0 (sv) * 1993-11-03 1993-11-03 Kabi Pharmacia Ab Method and means for prevention of cataract
JPH08134134A (ja) * 1994-11-09 1996-05-28 Nippon Shokubai Co Ltd 粒子状含水ゲル重合体の乾燥方法
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
JPH0995413A (ja) * 1995-09-29 1997-04-08 Shiseido Co Ltd 皮膚外用剤
GB9718568D0 (en) * 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
WO2000004916A1 (en) * 1998-07-23 2000-02-03 Societe De Conseils De Recherches Et D'applications Scientifiques Sas Encapsulation of water soluble peptides
EP1144456A3 (en) * 1999-01-12 2002-09-11 Vito-Mannan Polysaccharide L.L.C. Method of isolating mucilaginous polysaccharides and uses thereof
JP2001318350A (ja) * 2000-05-11 2001-11-16 Lion Corp コンタクトレンズ用溶液
AU2001261403B2 (en) * 2000-05-15 2006-04-06 The Procter & Gamble Company Compositions comprising cyclodextrin
US20020147232A1 (en) * 2000-05-26 2002-10-10 Claus Sundgreen Pharmaceutical compositions comprising desglymidodrine as an active drug substance
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
US6541510B2 (en) * 2000-09-28 2003-04-01 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds

Also Published As

Publication number Publication date
CA2484100C (en) 2012-01-03
US20080299166A1 (en) 2008-12-04
ZA200407794B (en) 2006-02-22
PL215579B1 (pl) 2013-12-31
CO5611168A2 (es) 2006-02-28
ES2392964T3 (es) 2012-12-17
HK1073070A1 (en) 2005-09-23
EP1499361B1 (en) 2012-08-08
IL164627A (en) 2009-11-18
US20050163853A1 (en) 2005-07-28
US20120040901A1 (en) 2012-02-16
PL371595A1 (en) 2005-06-27
CN1646171B (zh) 2010-05-26
KR101121675B1 (ko) 2012-03-13
RU2004133887A (ru) 2005-10-20
CA2484100A1 (en) 2003-10-30
EP1499361A1 (en) 2005-01-26
IL164627A0 (en) 2005-12-18
NZ535810A (en) 2007-11-30
MXPA04010325A (es) 2005-06-08
CN1646171A (zh) 2005-07-27
PT1499361E (pt) 2012-11-22
BR0309340A (pt) 2005-03-08
AU2003224099B2 (en) 2006-11-09
WO2003089008A1 (en) 2003-10-30
AU2003224099A1 (en) 2003-11-03
KR20040103968A (ko) 2004-12-09
JP4648632B2 (ja) 2011-03-09
RU2321597C2 (ru) 2008-04-10
JP2005529879A (ja) 2005-10-06

Similar Documents

Publication Publication Date Title
NO20044979L (no) Nye biomaterialer, deres fremstilling og anvendelse
Wang et al. Transformation of biomass DNA into biodegradable materials from gels to plastics for reducing petrochemical consumption
BRPI0418622A (pt) plantas auto-processantes e partes de planta
BR0313226A (pt) Uso de agentes de floculação para separar resìduo sólido em substratos de fermentação hidrolisados
WO2005061672A3 (en) Method of decomposition polymer
BR9813968A (pt) Moléculas de ácido nucléico que codificam proteìnas tendo atividade frutosil transferase e processos para produzir inulina de cadeia longa
WO2008125120A3 (en) Extract of trigonella foenum-graecum
BR0211028A (pt) Solução aquosa, método para formação de associações de fármaco e polìmero, composições farmacêuticas, método para formação de uma composição farmacêutica e produto
ATE478096T1 (de) Verwendung eines holzhydrolysats
Rente et al. Review of deep eutectic systems from laboratory to industry, taking the application in the cosmetics industry as an example
WO2008021574A3 (en) Modulating plant carotenoid levels
BRPI0412063A (pt) um método para produzir ácido orgánico
DE60119711D1 (de) Verfahren zur herstellung von funktionalierten polyalkyleniminen, diese enthaltende zusammenstellungen und ihre verwendungen
NO20034853D0 (no) Fargestoffer innkapslet i en polymermatrise
WO2009134996A3 (en) Method of conditioning a mixed liquor containing nonionic polysaccharides and/or nonionic organic molecules
AU2003234956A1 (en) Pesticidal pyridinecarboxamide derivatives
Hainal et al. Lignin as a carbon source for the cultivation of some Rhodotorula species
Rios et al. Pyruvate aldol condensation product: a metabolite that escaped synthetic preparation for over a century
Kim et al. Geopolymerization of biopolymers: a preliminary inquiry
JP2008072961A (ja) 高分子タンニンの酵素的架橋反応
AU2003263914A1 (en) Rosin-fatty acid vinylic polymer compositions
Usharani et al. Stabilization of collagen through bioconversion: An insight in protein–protein interaction
CN104326822A (zh) 一种小麦化肥及其制备方法
BR0115242A (pt) Processo para a preparação de uma resina alquìdica modificada por acrìlico, resina alquìdica modificada por acrìlico, processo para a preparação de uma composição de resina alquìdica modificada por acrìlico transportada por água, e, composições de resina alquìdica modificada por acrìlico transportada por água, e de revestimento
CN111138561A (zh) 一种基于高压剪切效应的壳寡糖绿色制备工艺

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application